Results 161 to 170 of about 16,485 (262)

Adenine at lower doses acts in the kidney as an aquaretic agent and prevents hyponatremia. [PDF]

Purinergic Signal
Alghamdi A, Thakar CV, Amlal H.
europepmc   +1 more source

DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis.

Blood
Laan S, Del Castillo Alferez J, Cannegieter S, Fijnvandraat K, Kruip M, le Cessie S, Bierings R, Eikenboom J, van Moort I.   +8 more
europepmc   +1 more source

Kidney collecting duct-derived vasopressin is not essential for appropriate concentration or dilution of urine.

Am J Physiol Renal Physiol
Zuchowski Y, Carty JS, Trapani JB, Watts JA, Bock F, Zhang M, Terker AS, Zent R, Delpire E, Harris RC, Arroyo JP.   +10 more
europepmc   +1 more source

How should menorrhagia be managed in people with bleeding disorders: A systematic review of the literature and thematic synthesis

Masood R, Dev V, Gee M, Finch K, Fletcher DM, Bamidele O, Traunter J, Allsup D, Guinn B.   +8 more
europepmc   +1 more source

ヒト腎プロスタグランジンE2,F2αに及ぼすArginine VasopressinおよびDeamino-8-D-arginine vasopressinの影響

ヒト腎プロスタグランジンE2,F2αに及ぼすArginine VasopressinおよびDeamino-8-D-arginine vasopressinの影響
openaire  

Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

New England Journal of Medicine, 1983
In a randomized double-blind cross-over trial we gave either 1-deamino-8-D-arginine vasopressin or placebo to 12 patients with uremia, hemorrhagic tendencies, and prolonged bleeding times. After vasopressin infusion, all patients had shortened bleeding times, with the effect lasting for at least four hours in most cases. Platelet count, platelet cyclic
P. Mannucci, G. Remuzzi, F. Pusineri, R. Lombardi, C. Valsecchi, G. Mecca, T. Zimmerman   +6 more
semanticscholar   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.

Journal of Medicinal Chemistry, 1976
Deamino[4-threonine,8-D-arginine]vasopressin (dTDAVP), deamino[8-D-arginine]vasopressin (dDAVP), [8-D-arginine[vasopressin (DAVP), and deamino-arginine-vasopressin (dAVP) were synthesized by the solid-phase method and tested for their biological activities.
M. Manning, L. Balaspiri, J. Moehring, J. Haldar, W. Sawyer   +4 more
semanticscholar   +3 more sources

Molecular mechanics calculations on deaminooxytocin and on deamino-arginine-vasopressin and its analogues

Journal of Computer-Aided Molecular Design, 1989
The backbone conformations of the cyclic moieties of 1-[beta-mercaptopropionic acid]-oxytocin [( Mpa1]-OT), [1-beta-mercaptopropionic acid]-arginine-vasopressin [( Mpa1]-AVP), [1-(beta'-mercapto-beta,beta-cyclopentamethylene)propionic acid]-arginine-vasopressin [( Cpp1]-AVP), and [1-thiosalicylic acid]-arginine-vasopressin [( Ths1]-AVP) have been ...
A. Liwo, A. Tempczyk, Z. Grzonka
semanticscholar   +3 more sources

Antidiuretic action of 1-deamino-(8-D-arginine)-vasopressin in unanesthetized rats.

The Journal of Pharmacology and Experimental Therapeutics, 1974
I. Vávra, A. Machová, I. Krejci
semanticscholar   +4 more sources

Oppositely directed actions of different doses of arginine-vasotocin and 1-deamino-arginine-vasotocin on sodium ion transport in skin of the frog Rana temporaria

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2011
In experiments on non-anesthetized female Wistar rats, it has been shown that injection of 1-deamino-arginine-vasotocin (1dAVT) increases sodium excretion and solute-free water reabsorption. Antagonists of V1-receptors (OPC-31260, Otsuka Pharmaceutical Co., Ltd., Japan) eliminates the effect water reabsorption whereas antagonist of V1-receptors (OPC ...
A. E. Bogolepova
semanticscholar   +3 more sources